DES patent spar
This article was originally published in The Gray Sheet
Executive Summary
J&J/Cordis plans to appeal July 1 Wilmington, Del. federal jury ruling that Cordis stents, including the sirolimus-eluting Cypher and the Bx Velocity family infringe on two Boston Scientific patents (1"The Gray Sheet," July, 4, 2005, p. 5)...
You may also be interested in...
No Summer Break? Legal, Enforcement Issues Tax Boston Scientific Counsel
Manhattan federal court will determine whether Boston Scientific is entitled to payment from Medinol for lost revenue associated with the Nir Flex stent
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.